Imaging Biomarkers of Treatment Response to Dexamethasone Implant in Macular Edema Due to Retinal Vascular Diseases - Diabetic Macular Edema and Retinal Vein Occlusion.
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
The purpose of this pilot study is to evaluate different imaging parameters in patients with previously treatment-naive DME and ME due to RVO before and after treatment with dexamethasone implant, in order to find specific retinal inflammatory and microvascular biomarkers that may be predictive of treatment outcome.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• previously untreated centre-involving DME or ME secondary to RVO with CMT ≥ 300 μm;
• pseudophakic eyes or eyes with a transparent lens or only initial sclerosis of the lens, in order to obtain good quality retinal imaging
• patient agreement to participate in the study.
Locations
Other Locations
Italy
MultiMedica IRCCS Multimedica
RECRUITING
Milan
Contact Information
Primary
Stela Vujosevic, MD
stela.vujosevic@multimedica.it
+30 02 85 99 4601
Backup
Gabriele Piccoli
gabriele.piccoli@multimedica.it
+30 02 85 99 4601
Time Frame
Start Date: 2023-10-17
Estimated Completion Date: 2025-12
Participants
Target number of participants: 50
Related Therapeutic Areas
Sponsors
Collaborators: AbbVie
Leads: IRCCS Multimedica